Portico Next Generation Approval Study
This study is looking at a new heart valve, called Portico™ NG, for people who have a serious condition called severe aortic stenosis. This means their heart's main valve doesn't open properly, making their heart work much harder. We're studying patients who are very unwell or have other health problems that make standard surgery risky. The main goal is to check if this new valve is safe and effective within the first 30 days after it's put in. We also want to know if it helps with blood leaking around the new valve. This research is important to help the new valve become widely available for patients who need it.
Auf einen Blick
Ergebnisse
Ergebnisse dieser Studie
Veröffentlicht July 2024Die Ergebnisse dieser Studie wurden veröffentlicht.
Worum geht es in dieser Studie?
This clinical study is evaluating a new type of heart valve replacement called the Portico™ NG Transcatheter Aortic Heart Valve. It's designed for patients with a condition called severe aortic stenosis. This is where the main valve in your heart (the aortic valve) becomes stiff and narrowed, making it hard for blood to flow out to the rest of your body. This can cause symptoms like chest pain, breathlessness, and dizziness.
The new valve is put in using a less invasive procedure, meaning doctors don't have to open up your chest as much as with traditional surgery. This study is specifically for people who are considered to be at high or extreme risk for open-heart surgery, often because they have other serious health issues or are very unwell. The information gathered from this study will help determine if the Portico™ NG valve is safe and works well enough to be approved for use by medical authorities in Europe and the United States.
Researchers will be looking closely at how patients recover after getting the new valve, focusing on things like overall health within 30 days and if there's any leaking around the new valve. They are also testing a slightly larger version of the valve, called the Navitor Titan™ valve, for some patients. The aim is to make sure these new options are good and safe ways to treat severe aortic stenosis for people who really need them.
Wichtige Erkenntnisse
- Tests a new heart valve (Portico™ NG) for severe aortic stenosis.
- Aims for patients at high risk for traditional heart surgery.
- Evaluates safety and how well the valve works.
- Involves a less invasive procedure to implant the valve.
- Requires follow-up appointments for up to five years.
- Information helps the valve get approved for wider use.
Wer könnte berechtigt sein?
This study is for adults generally aged between 18 and 100 years old. You might be suitable if you have severe aortic stenosis and symptoms like breathlessness or chest pain, and your doctors believe you are at high risk for traditional open-heart surgery. This 'high risk' could be due to your age, general health, or other medical problems.
To join, your aortic valve opening would need to be very narrow based on scans, and your heart valve measurements must fall within a specific range for the new valve to fit properly.
You would not be able to join if you've recently had a heart attack, a stroke, or certain blood disorders, or if you have an active stomach ulcer. If you've had other heart procedures recently or if you have a different type of heart valve problem that is more serious than your aortic stenosis, you would also not be able to take part.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Do I have severe aortic stenosis?
- Am I considered at high or extreme risk for open-heart surgery?
- Do I have symptoms like shortness of breath or chest pain?
- Have I had a heart attack or stroke in the last 6 months?
- Am I generally between 18 and 100 years old?
- Do I have any problems with blood clotting or active stomach ulcers?
Was beinhaltet die Teilnahme?
If you decide to take part in this study, you will first go through a screening process to check if you meet all the requirements. This involves various tests and scans. If you are eligible, you will have the new heart valve fitted. This procedure usually involves placing the valve through a small cut in your leg or another access point.
After the procedure, doctors will monitor you closely in the hospital until you are ready to go home. You will then have follow-up appointments at 30 days and 12 months after your procedure. Following that, you'll have annual check-ups for up to five years. These appointments will involve various assessments to see how you are recovering and how well the new valve is working. You won't be given any experimental medication, but your doctors will manage your care and regular medication as usual.
Potenzielle Risiken und Vorteile
Locations (28)
- Cedars-Sinai Medical CenterVerifizierte PostleitzahlLos Angeles, Vereinigte Staaten
- Los Robles Regional Medical CenterVerifizierte PostleitzahlThousand Oaks, Vereinigte Staaten
- Washington Hospital CenterVerifizierte PostleitzahlWashington D.C., Vereinigte Staaten
- Advocate Christ Medical CenterVerifizierte PostleitzahlOak Lawn, United States
- St. Vincent HospitalVerifizierte PostleitzahlIndianapolis, Vereinigte Staaten
- Via Christi Regional Medical CenterVerifizierte PostleitzahlWichita, Vereinigte Staaten
- Sparrow Clinical Research InstituteVerifizierte PostleitzahlLansing, United States
- Minneapolis Heart InstituteVerifizierte PostleitzahlMinneapolis, Vereinigte Staaten
- Atlantic Health System - Morristown Memorial HospitalVerifizierte PostleitzahlMorristown, United States
- Albany Medical CenterVerifizierte PostleitzahlAlbany, United States
- Columbia University Medical Center/NYPHVerifizierte PostleitzahlNew York, Vereinigte Staaten
- Montefiore Medical Center - Moses DivisionVerifizierte PostleitzahlNew York, Vereinigte Staaten
Häufige Fragen
What is severe aortic stenosis?
It's when the main valve in your heart narrows and stiffens, making it hard for blood to pump out, leading to symptoms like shortness of breath or chest pain.
What does 'high surgical risk' mean?
It means that having traditional open-heart surgery would be riskier for you due to your age, other health problems, or frailty.
Is this a new type of heart valve?
Yes, the study is testing a newer version of a replacement heart valve called Portico™ NG, which is put in using a less invasive method.
Wie lange werde ich in der Studie begleitet?
After the valve is fitted, you'll have follow-up appointments over five years to check on your health and the valve's performance.
Kann ich die Studie verlassen, wenn ich meine Meinung ändere?
Yes, you are free to leave the study at any point without it affecting your medical care.
Wie Sie mehr erfahren können
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.